Day One Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company...
Staff
Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022
Dr. Kellum Invited to Participate on Additional Featured PanelsTORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or...
The Biogen Foundation and Community Lab Celebrates 20 Years of Serving our Communities
The Biogen Foundation has granted $70 million to help underserved communities in advancing science education, health equity, and food securityMore...
Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer
- Seasoned Life Science Executive Brings Expertise in Ophthalmic Clinical Development, Including Advancement of Multiple Late-Stage Programs to Product Approval...
Trevena Announces the Publication of an Expert Review on the Clinical Profile of OLINVYK® in Post-Operative Care
CHESTERBROOK, Pa., June 14, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and...
Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B
Initial cohort one data suggest predictable and sustained Factor IX normalization, supporting additional dosing at the same low dose with...
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
NEW YORK and DURHAM, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX) today provided financial...
Ocugen Named Among Philadelphia’s ‘2022 Best Places to Work’
MALVERN, Pa., June 14, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and...
Clover Doses First Patient with SCB-219M in Phase 1 Trial for Chemotherapy-Induced Thrombocytopenia
-- Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SCB-219M in cancer patients with chemotherapy-induced thrombocytopenia,...
Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak
HERA has ordered 110,000 doses of the Company’s MVA-BN smallpox/monkeypox vaccine for donation to Member StatesDeliveries will start immediately and...
Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification
Alfred Health to receive first in nation portable MRI systems for point-of-care brain scansGUILFORD, Conn., June 14, 2022 (GLOBE NEWSWIRE)...
EsoCap holds a multidisciplinary advisory board meeting on Barrett’s esophagus
EsoCap AG organized a multidisciplinary scientific advisory board meeting with eight international experts in Barrett’s esophagus (BE) in ZurichEsoCap’s technology...
Mainz Biomed Appoints Vice President of Clinical Affairs to Lead US Clinical Studies in Support of FDA Submission
Jane Edwards, CCRA, RAC brings over 20 years of senior experience developing optimal product and clinical trial strategies in diagnostics...
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
Acquisition creates a global leader in out-of-hospital software solutionsAccelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S....
NorthX Biologics appoints industry veterans to its board of directors
MATFORS, Sweden, June 14, 2022 (GLOBE NEWSWIRE) -- Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and GMP manufacture...
Nicox: 2022 Ordinary Shareholder Meeting
Press ReleaseNicox: 2022 Ordinary Shareholder MeetingJune 14, 2022 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris:...
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants
CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines
-- Study to evaluate SCB-2019 (CpG 1018/Alum) as a heterologous booster in individuals previously vaccinated with CoronaVac™ (Sinovac Inactivated Vaccine), Comirnaty®...
Teleflex launches new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand
Designed to help clinicians overcome catheter identification confusionWAYNE, Pa., June 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a...
Bionomics Investor Webinar
ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a...